|1.||Herndon, David N: 18 articles (06/2015 - 08/2002)|
|2.||Frieden, Ilona J: 11 articles (09/2015 - 09/2009)|
|3.||Powell, Julie: 11 articles (02/2015 - 03/2011)|
|4.||Filippi, Luca: 10 articles (05/2015 - 01/2010)|
|5.||Pitman, Roger K: 10 articles (01/2015 - 01/2002)|
|6.||Abraldes, Juan G: 9 articles (01/2016 - 12/2002)|
|7.||García-Pagán, Juan Carlos: 9 articles (09/2015 - 02/2002)|
|8.||Bosch, Jaume: 8 articles (01/2016 - 02/2002)|
|9.||Bagnoli, Paola: 8 articles (05/2015 - 01/2010)|
|10.||Orr, Scott P: 8 articles (01/2015 - 01/2002)|
10/01/2014 - "The β-blocker propranolol was discovered to be highly effective for the treatment of infantile hemangiomas (IHs), since 2008. "
05/01/2014 - "After initiation of propranolol, most hemangiomas show evidence of significant improvement relatively rapidly, often within days. "
01/01/2014 - "Propranolol is highly effective in the treatment of infantile hemangioma (IH), but important clinical and pharmacological data are lacking. "
01/01/2014 - "Oral propranolol (PRN) has recently been shown to be highly effective for infantile hemangiomas (IHs), and is currently recommended as the first-line treatment of complicated IHs. "
01/01/2013 - "Recent reports of propranolol for the treatment of hemangiomas have led many physicians to question the best treatment strategy for children with vision-threatening hemangiomas. "
|2.||Hypertension (High Blood Pressure)
02/01/1986 - "The reduction of heart rate and cardiac index after propranolol were significantly greater in patients with essential hypertension than in control subjects (p less than 0.01, p less than 0.05, respectively). "
01/01/1986 - "Overall, both drugs were safe and effective in treating hypertension, but complaints of beta-blocker-associated side effects were more frequent with propranolol."
01/01/1979 - "In mild to moderately severe hypertension, propranolol, in does of up to 480 mg/day in combination with a thiazide diuretic, has been found to be effective in over 80% of patients on long-term therapy. "
08/01/1983 - "Treatment with propranolol (0.5 mg/kg) eliminated postapnea hypertension. "
04/01/2000 - "The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension."
|3.||Migraine Disorders (Migraine)
06/01/1990 - "Propranolol at a dosage of 2 mg/kg per day taken divided into three has shown to be the most beneficial in the prevention of migraine headaches. "
06/15/2011 - "The prophylactic effect of propranolol treatment on symptomatic migraine was demonstrated on the HI, which significantly improved (p<0.05). "
01/01/2004 - "Although many trials have relevant methodological shortcomings, there is clear evidence that propranolol is more effective than placebo in the short-term interval treatment of migraine. "
01/01/2004 - "We aimed to determine whether there is evidence that propranolol is more effective than placebo and as effective as other drugs for the interval (prophylactic) treatment of patients with migraine. "
10/01/2009 - "Many clinical trials have confirmed that propranolol is effective in the prophylactic treatment of migraine. "
02/01/2006 - "Life-table curves showed that prophylactic EVL and propranolol were similarly effective for primary prophylaxis of variceal bleeding (11/50 [22%]vs 12/50 [24%]; P = 0.68) and overall mortality (14/50 [28%]vs 12/50 [24%]; P = 0.49). "
07/01/1996 - "Two small studies reported that propranolol is effective in arresting mucosal hemorrhage from severe PHG. "
12/01/1988 - "Therapy with oral propranolol was effective in preventing any recurrence of gastrointestinal bleeding."
08/01/2009 - "The evaluation of acute HVPG response to i.v. propranolol before initiating secondary prophylaxis for variceal bleeding is a useful tool in predicting the efficacy of non-selective beta-blockers. "
01/01/2015 - "This large study of children with EHPVO demonstrates the efficacy of propranolol in the reduction of gastrointestinal bleeding in children with EHPVO. "
08/01/1986 - "Seventy three patients (63 males and 10 females) aged 41-75 years with established stable exertional angina pectoris were studied in a double-blind fashion to confirm the efficacy of 80 mg propranolol administered three times daily and also to examine its effect on ST-segment changes in the electrocardiogram by ambulatory ST-segment monitoring and exercise testing using on-line computer analysis. "
06/01/1994 - "Intranasal propranolol has been shown to improve exercise tolerance in patients with angina pectoris. "
11/01/1993 - "Improvement in exercise tolerance and immediate beta-adrenergic blockade with intranasal propranolol in patients with angina pectoris."
02/01/1989 - "[Comparative study of various schedules of administration of propranolol to patients with stenocardia (a cooperative study)]."
04/01/1988 - "In the present study, the incidence and clinical significance of ST-segment fluctuation were studied before and after propranolol in 52 patients with angina pectoris. "
|7.||Adrenergic Receptors (Adrenergic Receptor)
|4.||Drug Therapy (Chemotherapy)